EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study

Cheng-Hsun Chuang, Ping-Kun Tsai, Shih-Wen Kao, Yu-Hsun Wang, Chao-Bin Yeh

Oncology Research · 2026

DOI: 10.32604/or.2025.072875 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Oncology Research, 2026. Verfasst von Cheng-Hsun Chuang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Neoplasms, Hypoglycemic Agents. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor AgonistsNeoplasmsHypoglycemic AgentsHumansFemaleMiddle AgedMaleAgedRetrospective StudiesAdultBody Mass IndexRisk Factors

Stichwörter der Autor:innen

Glucagon-like peptide-1 (GLP-1) receptor agonistscancer riskcohort studyobesitytype 2 diabetes mellitus

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents

Autor:innen und Institutionen

  • Institute of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan.
  • Department of Emergency Medicine, School of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan.
  • Department of Emergency Medicine, Chung Shan Medical University Hospital, Taichung, 402, Taiwan.
  • Department of Internal Medicine, Zuoying Armed Forces General Hospital, Kaohsiung, 813, Taiwan.
  • Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan.
  • Graduate Institute of Aerospace and Undersea Medicine, College of Biomedical Sciences, National Defense Medical University, Taipei, 114, Taiwan.

Zitieren

APA

Chuang, C. H., Tsai, P. K., Kao, S. W., Wang, Y. H., & Yeh, C. B. (2026). Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study. Oncology Research. https://doi.org/10.32604/or.2025.072875

Vancouver

Chuang CH, Tsai PK, Kao SW, Wang YH, Yeh CB. Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study. Oncology Research. 2026. doi:10.32604/or.2025.072875

BibTeX
@article{Chuang2026,
  author = {Chuang, Cheng-Hsun and Tsai, Ping-Kun and Kao, Shih-Wen and Wang, Yu-Hsun and Yeh, Chao-Bin},
  title = {Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2025.072875}
}
Kostenlos starten →